Evidence map›Paper›PMID 32499616›Full record

ArticleNature cell biology2020

Publisher Correction: ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism.

Sarah Theresa Boyle, Valentina Poltavets, Jasreen Kular, Natasha Theresa Pyne, Jarrod John Sandow, Alexander Charles Lewis, Kendelle Joan Murphy, Natasha Kolesnikoff, Paul Andre Bartholomew Moretti, Melinda Nay Tea and 8 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Sarah Theresa BoyleCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0001-6143-9285
Valentina PoltavetsCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Jasreen KularCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Natasha Theresa PyneCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Jarrod John SandowDivision of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0001-5684-8236
Alexander Charles LewisCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Kendelle Joan MurphyThe Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Cancer Division, St Vincent's Clinical School, University of NSW, Sydney, New South Wales, Australia.
Natasha KolesnikoffCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Paul Andre Bartholomew MorettiCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Melinda Nay TeaCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Vinay TergaonkarCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Paul TimpsonThe Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Cancer Division, St Vincent's Clinical School, University of NSW, Sydney, New South Wales, Australia.
Stuart Maxwell PitsonCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Andrew Ian WebbDivision of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Robert John WhitfieldBreast, Endocrine and Surgical Oncology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0001-5061-6995
Angel Francisco LopezCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Marina KochetkovaCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia. Marina.Kochetkova@unisa.edu.au.ORCID http://orcid.org/0000-0002-0599-7378
Michael Susithiran SamuelCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia. Michael.Samuel@unisa.edu.au.ORCID http://orcid.org/0000-0001-7880-6379

Funding

Department of Education and Training | Australian Research Council (ARC) FT120100132Department of Health | National Health and Medical Research Council (NHMRC) GNT1103712Department of Health | National Health and Medical Research Council (NHMRC) GNT1145319
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32499616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.